Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo. (2024)
Attributed to:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.virol.2023.109954
PubMed Identifier: 38086284
Publication URI: http://europepmc.org/abstract/MED/38086284
Type: Journal Article/Review
Volume: 590
Parent Publication: Virology
ISSN: 0042-6822